Form 4: Henry Schein Executive Sells Shares Under 10b5-1 Plan

Thomas C. Popeck, CEO of Henry Schein Products, sold 1,355 shares of Henry Schein Inc. common stock for $72.79 per share under a Rule 10b5-1 plan.

Summary

• Thomas C. Popeck, CEO of Henry Schein Products, reported a sale of Henry Schein Inc. (HSIC) common stock.
• The transaction involved the disposition of 1,355 shares of common stock.
• The shares were sold at a price of $72.79 per share.
• Following this transaction, Popeck beneficially owns 86,182 shares of common stock.
• The sale was executed on March 19, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale, the execution under a Rule 10b5-1 plan suggests it's a pre-scheduled personal financial management activity rather than a reaction to new company-specific news.

Negatives

• An insider, Thomas C. Popeck, sold 1,355 shares of company stock.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when executed under Rule 10b5-1 plans, are routinely monitored by investors for potential signals regarding management's perception of future stock performance. In the healthcare distribution industry, such sales are common for executives managing personal finances and are often pre-scheduled to avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• Insider sales are a standard component of executive compensation and personal financial planning across all industries.
• The volume of 1,355 shares sold is relatively small compared to the total beneficial ownership of 86,182 shares, suggesting this is likely a routine liquidity event rather than a significant divestment of holdings.

Stakeholder Impact

• Shareholders: May view the insider sale with slight caution, though the execution under a Rule 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects.

Key Dates

Recommendation

The sale of 1,355 shares by an executive, executed under a Rule 10b5-1 plan, is a routine event for personal financial management and does not indicate a material change in the company's fundamentals or outlook. It is not significant enough to warrant a change in investment recommendation.

Keywords

Henry Schein, HSIC, Insider Trading, Form 4, Stock Sale, Thomas C. Popeck, CEO, Rule 10b5-1